Titre : Intégrine bêta4

Intégrine bêta4 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Overbite
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Intégrine bêta4 : Questions médicales les plus fréquentes", "headline": "Intégrine bêta4 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Intégrine bêta4 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-20", "dateModified": "2025-04-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Intégrine bêta4" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Chaines bêta des intégrines", "url": "https://questionsmedicales.fr/mesh/D039641", "about": { "@type": "MedicalCondition", "name": "Chaines bêta des intégrines", "code": { "@type": "MedicalCode", "code": "D039641", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.200" } } }, "about": { "@type": "MedicalCondition", "name": "Intégrine bêta4", "alternateName": "Integrin beta4", "code": { "@type": "MedicalCode", "code": "D039663", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Wenjie Huang", "url": "https://questionsmedicales.fr/author/Wenjie%20Huang", "affiliation": { "@type": "Organization", "name": "Department of Reproductive Medicine, Liuzhou Maternity and Child Healthcare Hospital, Affiliated Women and Children's Hospital of Guangxi University of Science and Technology, Liuzhou, Guangxi, 545001, People's Republic of China." } }, { "@type": "Person", "name": "Yinxiu Chi", "url": "https://questionsmedicales.fr/author/Yinxiu%20Chi", "affiliation": { "@type": "Organization", "name": "School of Basic Medicine, Central South University, Changsha, Hunan, 410078, People's Republic of China." } }, { "@type": "Person", "name": "Jingjing Li", "url": "https://questionsmedicales.fr/author/Jingjing%20Li", "affiliation": { "@type": "Organization", "name": "Department of Reproductive Medicine, Liuzhou Maternity and Child Healthcare Hospital, Affiliated Women and Children's Hospital of Guangxi University of Science and Technology, Liuzhou, Guangxi, 545001, People's Republic of China." } }, { "@type": "Person", "name": "Jia Liu", "url": "https://questionsmedicales.fr/author/Jia%20Liu", "affiliation": { "@type": "Organization", "name": "Shenzhen Jiake Biotechnology, Shenzhen, China." } }, { "@type": "Person", "name": "Michael Bachmann", "url": "https://questionsmedicales.fr/author/Michael%20Bachmann", "affiliation": { "@type": "Organization", "name": "Department of Cell Physiology and Metabolism, University of Geneva, Centre Médical Universitaire, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The development of a novel Orthodontic Alignment Index and its use to evaluate the effect of residual overjet on the stability of the alignment of the maxillary anterior dentition.", "datePublished": "2022-12-28", "url": "https://questionsmedicales.fr/article/36575336", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40510-022-00444-1" } }, { "@type": "ScholarlyArticle", "name": "Long term stability of a high-angle skeletal Class II open bite treated with high-pull headgear and modified transpalatal arch: A case report.", "datePublished": "2022-12-13", "url": "https://questionsmedicales.fr/article/36521308", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ortho.2022.100717" } }, { "@type": "ScholarlyArticle", "name": "Are morphological and morphometric characteristics of maxillary anterior region and nasopalatine canal related to each other?", "datePublished": "2022-08-08", "url": "https://questionsmedicales.fr/article/35941313", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11282-022-00647-6" } }, { "@type": "ScholarlyArticle", "name": "Malocclusion complexity and orthodontic treatment need in children with autism spectrum disorder.", "datePublished": "2022-06-15", "url": "https://questionsmedicales.fr/article/35701552", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00784-022-04578-8" } }, { "@type": "ScholarlyArticle", "name": "Dental manifestation and management in a patient with combined pituitary hormone deficiency: a two-year case report.", "datePublished": "2023-09-03", "url": "https://questionsmedicales.fr/article/37732453", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.22514/jocpd.2023.069" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Récepteurs de surface cellulaire", "item": "https://questionsmedicales.fr/mesh/D011956" }, { "@type": "ListItem", "position": 6, "name": "Récepteurs immunologiques", "item": "https://questionsmedicales.fr/mesh/D011971" }, { "@type": "ListItem", "position": 7, "name": "Intégrines", "item": "https://questionsmedicales.fr/mesh/D016023" }, { "@type": "ListItem", "position": 8, "name": "Chaines bêta des intégrines", "item": "https://questionsmedicales.fr/mesh/D039641" }, { "@type": "ListItem", "position": 9, "name": "Intégrine bêta4", "item": "https://questionsmedicales.fr/mesh/D039663" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Intégrine bêta4 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Intégrine bêta4", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Intégrine bêta4", "description": "Comment diagnostiquer une anomalie d'intégrine bêta4 ?\nQuels examens sont utilisés pour évaluer l'intégrine bêta4 ?\nY a-t-il des marqueurs associés à l'intégrine bêta4 ?\nQuels symptômes peuvent indiquer un problème d'intégrine bêta4 ?\nPeut-on détecter l'intégrine bêta4 dans le sang ?", "url": "https://questionsmedicales.fr/mesh/D039663?mesh_terms=Overbite&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Intégrine bêta4", "description": "Quels symptômes sont liés à une déficience d'intégrine bêta4 ?\nL'intégrine bêta4 affecte-t-elle la mobilité cellulaire ?\nY a-t-il des signes cliniques d'une anomalie d'intégrine bêta4 ?\nLes troubles de l'intégrine bêta4 causent-ils des douleurs ?\nL'intégrine bêta4 est-elle impliquée dans des maladies spécifiques ?", "url": "https://questionsmedicales.fr/mesh/D039663?mesh_terms=Overbite&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Intégrine bêta4", "description": "Comment prévenir les complications liées à l'intégrine bêta4 ?\nY a-t-il des mesures préventives pour les maladies associées ?\nLes vaccinations peuvent-elles aider ?\nEst-il possible de modifier son mode de vie pour prévenir les problèmes ?\nLes soins dermatologiques réguliers sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D039663?mesh_terms=Overbite&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Intégrine bêta4", "description": "Quels traitements existent pour les anomalies d'intégrine bêta4 ?\nPeut-on utiliser des médicaments pour cibler l'intégrine bêta4 ?\nLa thérapie cellulaire peut-elle aider avec l'intégrine bêta4 ?\nY a-t-il des traitements topiques pour les problèmes cutanés ?\nLes greffes de peau sont-elles une option pour les déficiences d'intégrine ?", "url": "https://questionsmedicales.fr/mesh/D039663?mesh_terms=Overbite&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Intégrine bêta4", "description": "Quelles complications peuvent survenir avec une anomalie d'intégrine bêta4 ?\nLes anomalies d'intégrine bêta4 peuvent-elles entraîner des cancers ?\nY a-t-il des risques de complications à long terme ?\nLes complications peuvent-elles affecter d'autres systèmes ?\nComment gérer les complications liées à l'intégrine bêta4 ?", "url": "https://questionsmedicales.fr/mesh/D039663?mesh_terms=Overbite&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Intégrine bêta4", "description": "Quels sont les facteurs de risque pour les anomalies d'intégrine bêta4 ?\nL'exposition au soleil est-elle un facteur de risque ?\nLes maladies auto-immunes augmentent-elles le risque ?\nLe tabagisme est-il un facteur de risque ?\nL'âge joue-t-il un rôle dans les anomalies d'intégrine bêta4 ?", "url": "https://questionsmedicales.fr/mesh/D039663?mesh_terms=Overbite&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie d'intégrine bêta4 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses de tissus peuvent révéler des anomalies d'intégrine bêta4." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer l'intégrine bêta4 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'immunohistochimie et la cytométrie en flux sont couramment utilisés." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs associés à l'intégrine bêta4 ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des marqueurs comme l'alpha6 intégrine sont souvent associés à l'intégrine bêta4." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème d'intégrine bêta4 ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des problèmes cutanés, des troubles de la cicatrisation et des anomalies de la migration cellulaire." } }, { "@type": "Question", "name": "Peut-on détecter l'intégrine bêta4 dans le sang ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'intégrine bêta4 est principalement présente dans les tissus, pas dans le sang." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une déficience d'intégrine bêta4 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des lésions cutanées, des infections fréquentes et des problèmes de cicatrisation." } }, { "@type": "Question", "name": "L'intégrine bêta4 affecte-t-elle la mobilité cellulaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une déficience peut entraîner des problèmes de migration cellulaire." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques d'une anomalie d'intégrine bêta4 ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans la structure des tissus et des problèmes d'adhésion cellulaire." } }, { "@type": "Question", "name": "Les troubles de l'intégrine bêta4 causent-ils des douleurs ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs peuvent survenir en raison de lésions cutanées et d'infections." } }, { "@type": "Question", "name": "L'intégrine bêta4 est-elle impliquée dans des maladies spécifiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est liée à des maladies comme l'épidermolyse bulleuse et certains cancers." } }, { "@type": "Question", "name": "Comment prévenir les complications liées à l'intégrine bêta4 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hygiène et des soins appropriés des plaies peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives pour les maladies associées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce et la surveillance régulière sont recommandés." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles aider ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations peuvent prévenir certaines infections associées aux déficiences cutanées." } }, { "@type": "Question", "name": "Est-il possible de modifier son mode de vie pour prévenir les problèmes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain et une alimentation équilibrée peuvent renforcer le système immunitaire." } }, { "@type": "Question", "name": "Les soins dermatologiques réguliers sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins dermatologiques réguliers peuvent prévenir les complications cutanées." } }, { "@type": "Question", "name": "Quels traitements existent pour les anomalies d'intégrine bêta4 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des thérapies géniques et des soins dermatologiques." } }, { "@type": "Question", "name": "Peut-on utiliser des médicaments pour cibler l'intégrine bêta4 ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des inhibiteurs spécifiques de l'intégrine bêta4 sont en cours de recherche." } }, { "@type": "Question", "name": "La thérapie cellulaire peut-elle aider avec l'intégrine bêta4 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie cellulaire peut améliorer la fonction des cellules affectées." } }, { "@type": "Question", "name": "Y a-t-il des traitements topiques pour les problèmes cutanés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des crèmes et des onguents peuvent aider à traiter les lésions cutanées." } }, { "@type": "Question", "name": "Les greffes de peau sont-elles une option pour les déficiences d'intégrine ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les greffes de peau peuvent être nécessaires dans les cas graves." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une anomalie d'intégrine bêta4 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des infections, des cicatrices hypertrophiques et des problèmes de cicatrisation." } }, { "@type": "Question", "name": "Les anomalies d'intégrine bêta4 peuvent-elles entraîner des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines anomalies sont associées à un risque accru de cancers cutanés." } }, { "@type": "Question", "name": "Y a-t-il des risques de complications à long terme ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications chroniques peuvent affecter la qualité de vie." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter d'autres systèmes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications peuvent également toucher le système immunitaire et les organes." } }, { "@type": "Question", "name": "Comment gérer les complications liées à l'intégrine bêta4 ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une gestion multidisciplinaire est souvent nécessaire pour traiter les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies d'intégrine bêta4 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux, des maladies génétiques et des facteurs environnementaux." } }, { "@type": "Question", "name": "L'exposition au soleil est-elle un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition excessive au soleil peut aggraver les problèmes cutanés liés à l'intégrine." } }, { "@type": "Question", "name": "Les maladies auto-immunes augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent être associées à des anomalies d'intégrine." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut affecter la santé cutanée et augmenter le risque d'infections." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans les anomalies d'intégrine bêta4 ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter la fonction des intégrines et la santé cutanée." } } ] } ] }

Sources (86 au total)

The development of a novel Orthodontic Alignment Index and its use to evaluate the effect of residual overjet on the stability of the alignment of the maxillary anterior dentition.

It is thought that achieving a normal overjet may help to stabilise the alignment of the maxillary anterior dentition. Little's Irregularity Index is limited in assessing discrete post-orthodontic cha... To compare the post-treatment stability of maxillary anterior dental alignment in subjects treated either to a Class I incisor relationship or an increased overjet (> 4 mm) following fixed appliance-b... The Orthodontic Alignment Index (OAI) was developed and validated using a panel of 63 raters. The new index accounts for a range of weighted features including contact point displacement, spacing, rec... Eighty-two participants were included with a positive correlation observed between LII and OAI at the 12-month post-treatment review with a 1-mm increase in LII associated with a 2-point increase in t... Using a novel index (OAI) and LII, there was limited post-treatment relapse in alignment of the maxillary anterior dentition over a 12-month period. Based on this retrospective evaluation, achieving a...

Are morphological and morphometric characteristics of maxillary anterior region and nasopalatine canal related to each other?

The main purpose of this article was to clarify the relationship of anterior bone and tooth morphology with NPC. The anatomical features of the NPC region in three dimensions from coronal, axial, and ... In this retrospective study, CBCTs of a total of 330 individuals between the ages of 17 and 82 were evaluated. The effects of SRP, AOD, CI/PP angle, NPC/PP angle and CA on the anatomical features of N... While the SRPs, CI/PP angle, NPC/PP angle, CA, and age did not differ statistically according to NPC shape (p > 0.05), NPC shape varied according to gender and AOD (p < 0.05). It was found that cylind... The results showed that gender and AOD are influential factors on NPC shape. While conical-shaped NPC is more common in individuals with bite depth incisal, cylindrical-shaped NPC is more likely to be...

Malocclusion complexity and orthodontic treatment need in children with autism spectrum disorder.

This study aimed to investigate the malocclusion complexity and orthodontic treatment need among children with and without autism spectrum disorder (ASD) referred for orthodontic treatment by quantify... Dental records of 48 ASD and 49 non-ASD consecutive patients aged between 9 and 18 years (median age 13.0 years) referred for orthodontic treatment were reviewed and compared. The Discrepancy Index (D... The results show that both malocclusion complexity (DI, p = 0.0010) and orthodontic treatment need (IOTN-DHC, p = 0.0025; IOTN-AC p = 0.0009) were significantly higher in children with ASD. Furthermor... Malocclusion complexity and orthodontic treatment need are statistically significantly higher among children with ASD than children without ASD, independent of age and sex.... Children with autism may benefit from visits to a dental specialist (orthodontist) to prevent, to some extent, developing malocclusions from an early age....

Step-back anterior repositioning splint retraction for temporomandibular joint disc displacement with reduction in adult patients.

Anterior repositioning splint (ARS) is used to treat temporomandibular joint (TMJ) disc displacement with reduction (DDwR). However, high recurrence rate remains a problem especially in patients with ... This study optimised standard ARS therapy and proposed a step-back ARS retraction (SAR) method in adult patients with DDwR.... Dental examinations and magnetic resonance imaging of TMJ were obtained before treatment (T0), 1 to 3 months (T1), 3 to 6 months (T2) and 6 to 12 months (T3) during treatment in 48 adults (average age... The maximum interincisal opening was increased from 44.3 ± 6.9 to 45.3 ± 6.3 mm (p < .01), and joint pain was alleviated after ARS treatment. The overall success rate of ARS wearing was 92.1% (58/63) ... ARS treatment could improve mouth opening and joint symptoms in adult DDwR patients. SAR method was suitable for treating DDwR patients with deep overbite and overjet and improved retrodiscal tissue a...

The efficacy of anterior open bite closure when using Invisalign's optimized extrusion versus conventional attachments.

Clear aligners are reported to control anterior open bites. Despite this, anterior extrusion remains difficult with aligners. Optimized extrusion attachments on incisors may facilitate anterior extrus... This was a retrospective cohort study. The pre- and post-treatment intraoral scans of patients with anterior open bite treated with Invisalign aligners were assessed. Patients were divided into two gr... A total of 86 patients were included. Both groups showed significant increases in overbite, but there was no difference in the open bite correction efficacy in patients with conventional versus optimi... Anterior open bite can be corrected regardless of the attachment type. Optimized attachments are no more effective than using conventional attachments in incisor extrusion to correct open bite. Patien...

Effectiveness and predictability of treatment with clear orthodontic aligners: A scoping review.

In an ideal clinical setting, orthodontic therapy with clear aligners (CA) should improve the patients' initial malocclusion and must guarantee equivalence between the results predicted and those obta... A systematic computerized search was performed in 3 databases: PubMed, Scopus, and Embase. Inclusion criteria selected observational and clinical studies performed in at least 10 adult orthodontic pat... The 3 database computerized searches resulted in 1,553 articles, and 169 full texts were considered potentially relevant. After applying the eligibility criteria, 33 studies were included. Most studie... The studies have demonstrated improvement of initial malocclusion through CA treatments. Still, predictability degree is overestimated and does not accurately reflect the occlusion immediately at the ...

Critical appraisal of confounding factors of observational studies on the association between dentofacial features and dental trauma in a Brazilian population.

Dental trauma is a highly prevalent dental emergency. Children and adolescents without inadequate lip coverage, increased overjet, and anterior open bite are associated with the occurrence of traumati... Studies included in the qualitative synthesis of a recently published comprehensive systematic review and meta-analysis on the topic were screened. Studies that only mentioned the performance of bivar... Fifty-five observational studies were screened, of which 11 were excluded due to the mention of only bivariate analyzes or the lack of multivariate analyses. The remaining 44 studies were critically a... Most studies did not acknowledge the control for possible confounding factors and rarely stressed the need for caution in interpreting their results. Cross-sectional studies do not allow inferring a c...

Stability of Class II malocclusion treatment with Class II elastics.

The objective of this study was to compare the long-term cephalometric stability after successful therapy of nonextraction Class II malocclusion with elastics and with headgear.... The sample comprised 43 patients with Class II malocclusion and was divided into 2 groups. The elastic group (EG) consisted of 20 patients treated with fixed appliances associated with Class II elasti... The groups were matched regarding initial age, time of long-term posttreatment evaluation, initial malocclusion severity, quality of treatment result, and all pretreatment cephalometric variables. Int... Nonextraction Class II malocclusion treatment with elastics or extraoral headgear have similar long-term posttreatment stability....